Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2001Anti-Cancer Drugs

Efficacy and toxicity of bendamustine in patients with relapsed low-grade non-Hodgkinʼs lymphomas

View Full Paper
Ask AI
Bookmark
Share

Authors

AHAndrea HeiderNNN. Niederle

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Heider et al. (2001) studied this question.

synapsesocial.com/papers/6a80d599d7cc36764365df17https://doi.org/10.1097/00001813-200110000-00003
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma1991 · 162 citations
  2. 2IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma1997 · 1,712 citations